CMS Ready to Impose Plan Reform

Dermatologists who administer chemotherapy and other drugs in their offices could see significant reductions in reimbursement levels as a result of an effort by the federal government to curtail Medicare's costs for drugs used to treat cancer.

Related Videos
Dr. Suneel Chilukuri
Health Care Impacts on Gender and Sexual Minority Patients
Caring for Gender and Sexual Minority Patients
Related Content

WHO Calls For Caution When it Comes to Using AI For Health

June 2nd 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals

May 26th 2023

Rules & Regulations on Cosmetic Procedures: Where Are They?

May 16th 2023

Getting Started With Practice Tech: Pearls From Brandon Beal, MD

May 8th 2023

APPs May Fill in Gaps Due to Growing Shortages of Physicians, Nurses

May 8th 2023

WHO Calls For Caution When it Comes to Using AI For Health

June 2nd 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals

May 26th 2023

Rules & Regulations on Cosmetic Procedures: Where Are They?

May 16th 2023

Getting Started With Practice Tech: Pearls From Brandon Beal, MD

May 8th 2023

APPs May Fill in Gaps Due to Growing Shortages of Physicians, Nurses

May 8th 2023

WHO Calls For Caution When it Comes to Using AI For Health

June 2nd 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals

May 26th 2023

Rules & Regulations on Cosmetic Procedures: Where Are They?

May 16th 2023

Getting Started With Practice Tech: Pearls From Brandon Beal, MD

May 8th 2023

APPs May Fill in Gaps Due to Growing Shortages of Physicians, Nurses

May 8th 2023
© 2023 MJH Life Sciences

All rights reserved.